Immunohistochemistry scores showed that TMEM106A is most highly expressed in high‐grade tumors, especially in IDH‐wildtype gliomas, whereas the intensity of TMEM106A staining in IDH‐mutant tumors remains comparatively subdued. The gene discussed is TMEM106A; the disease is central nervous system cancer.